Long-acting galenical formulation for GRF peptides
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 27, 2001
Grant Date -
N/A
app pub date -
Aug 18, 1998
filing date -
Jun 14, 1996
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to a long-acting galenical formulation of GRF peptides, GRF and/or analogs thereof which comprises about 1 to about 100 mg of a GRF peptide, fragment or analog thereof pressed from about 1 to about 100 kg/mm.sup.2 in a tablet for parenteral administration, whereby these GRF peptides are released as the tablet is eroded.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully